RNA-seq
Viome Life Sciences Raises $25M in Series D Financing
The firm said that it plans to use the money to help launch its diagnostics division, expand its testing menu, and hire a chief operating officer.
Foundation Medicine, Merus to Develop CDx for Cancer Drug to Treat Patients With NRG1 Fusions
The companies will use Foundation's RNA sequencing platform to develop a companion diagnostic for Merus' bispecific antibody zenocutuzumab.
BostonGene, Sylvester Comprehensive Cancer Center Partner on Hematologic Cancer Molecular Subtyping
Researchers will compare traditional tumor profiling methods such as FISH and cytogenetics to BostonGene's AI-powered molecular and immune profiling platform.
MGI Tech, Predica Diagnostics Partner to Develop RNA-Based Cancer Screening Tests
The companies will combine Predica’s proprietary circular probe-based RNA-seq technology with MGI’s DNBSeq platforms for early cancer detection.
OmnigenicsAI, MultiplAI Health to Merge, Go Public in $340M SPAC Deal
The transaction, which is expected to close midyear, will result in OmnigenicsAI becoming publicly traded on the Nasdaq under the ticker symbol OMNI.
Mar 12, 2024
Mar 30, 2023
Feb 24, 2022
May 19, 2021
Mar 24, 2021